procaterol has been researched along with Substance Withdrawal Syndrome in 1 studies
Procaterol: A long-acting beta-2-adrenergic receptor agonist.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tamaoki, J | 1 |
| Kondo, M | 1 |
| Sakai, N | 1 |
| Nakata, J | 1 |
| Takemura, H | 1 |
| Nagai, A | 1 |
| Takizawa, T | 1 |
| Konno, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Fractional Concentration of Exhaled NO(FeNO) to Direct The Treatment of Sub-acute Cough：A Prospective, Open Label, Randomized and Placebo-Controlled Trial[NCT02655562] | Phase 4 | 200 participants (Anticipated) | Interventional | 2016-04-30 | Suspended (stopped due to There are difficulties in recruiting patients) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for procaterol and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Beclomethasone; | 1997 |